These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4430583)

  • 1. The choleretic action of sodium tyropanoate (bilopaque sodium) in the dog: preliminary observation.
    Nelson JA; Straubus AE; Amberg JR
    Invest Radiol; 1974; 9(6):438-43. PubMed ID: 4430583
    [No Abstract]   [Full Text] [Related]  

  • 2. The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid.
    Berk RN; Loeb PM; Cobo-Frenkel A; Barnhart JL
    Invest Radiol; 1977; 12(1):85-95. PubMed ID: 838560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic excretion of cholecystopaques introduced into the canine jejunum.
    Menuck L; Amberg JR; Bates M
    Invest Radiol; 1977; 12(1):106-8. PubMed ID: 138663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and physiology of the biliary radiographic contrast materials.
    Berk RN; Loeb PM
    Semin Roentgenol; 1976 Jul; 11(3):147-56. PubMed ID: 133461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 9. [The uricosuric effect of bilopaque (sodium tyropanoate). A contribution to the problem of nephro-toxicity of oral biliary contrast media].
    Burgener FA; Fischer HW
    Fortschr Geb Rontgenstr Nuklearmed; 1972 Dec; 117(6):685-8. PubMed ID: 4346201
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial of bilopaque (tyropanoate sodium) oral cholecystography. Evaluation of time for the optimal and peak opacification of the gallbladder.
    Han SY; Witten DM
    Radiology; 1974 Sep; 112(3):529-30. PubMed ID: 4843280
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiographic appearance of the nonabsorbed (unconjugated) and conjugated sodium tyropanoate (Bilopaque) in the bowel.
    Muhletaler CA; Gerlock AJ; Amberg JR; Avant GR
    Invest Radiol; 1982; 17(5):506-9. PubMed ID: 7141832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral cholecystography in the early phase of acute alcoholic pancreatitis. A prospective, randomized comparison of Telepaque and Bilopaque.
    Smith HJ; Corbett DB; Loeb PM; Peterson WL
    Invest Radiol; 1982; 17(6):629-33. PubMed ID: 6759457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)].
    Kasezawa N; Tazawa R; Urushibata S; Kobayashi M
    Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative evaluation of a new oral cholecystographic agent bilopaque with orabilex.
    JUDKINS MP BILLIMORIA PE; DOTTER CT
    Am J Roentgenol Radium Ther Nucl Med; 1963 Apr; 89():859-63. PubMed ID: 14042043
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial of Bilopaque, a new contrast medium for oral cholecystography].
    Magos E; Delhaye J; Dejong M
    J Belge Radiol; 1976; 59(4):369-76. PubMed ID: 795805
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical comparison of locetamic acid, lopanoic acid and tyropanoate sodium.
    Marshall TR
    J Indiana State Med Assoc; 1976 Oct; 69(10):742-3. PubMed ID: 135811
    [No Abstract]   [Full Text] [Related]  

  • 17. RENAL TOXICITY OF ORAL CHOLECYSTOGRAPHIC MEDIA. BUNAMIODYL SODIUM AND IOPANOIC ACID.
    WENNBERG JE; OKUN R; HINMAN EJ; NORTHCUTT RC; GRIEP RJ; WALKER WG
    JAMA; 1963 Nov; 186():461-7. PubMed ID: 14085024
    [No Abstract]   [Full Text] [Related]  

  • 18. Conjugated sodium tyropanoate (Bilopaque) in the bowel: significance of its presence or absence after first-dose oral cholecystography.
    Muhletaler CA; Gerlock AJ; Avant GR
    Radiology; 1981 Nov; 141(2):311-6. PubMed ID: 7291552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinico-radiological study of 3 radiopaque substances used in oral cholecystography].
    Ipinza I
    Rev Med Chil; 1982 Aug; 110(8):761-5. PubMed ID: 7156610
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicologic and pharmacologic properties of iocetamic acid, a new oral cholecystographic agent.
    Janbroers JM; Sanders JC; Til HP; Feron VJ; De Groot AP
    Toxicol Appl Pharmacol; 1969 Mar; 14(2):232-41. PubMed ID: 5772846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.